Biotech

All Articles

Metsera join Amneal to latch down GLP-1 supply

.With early phase 1 records right now out in bush, metabolic condition outfit Metsera is throwing aw...

Rivus posts data to support muscle-sparing being overweight drug cases

.Rivus Pharmaceuticals has actually revealed the information behind its own phase 2 being overweight...

BMS pays for $110M to form T-cell therapy contract, assisting Best purchase time to improve prioritized pipe

.Bristol Myers Squibb is paying for Top Medicine $110 million ahead of time to establish reagents fo...

Generate gains yet another $1B-plus Huge Pharma partnership

.Novartis has tattooed a bargain likely worth greater than $1 billion along with Flagship-founded Ge...

Metsera GLP-1 information piece shows 7.5% fat loss at 36 days

.Just recently debuted Metsera is unfolding some period 1 information for its own GLP-1 receptor ago...

Flagship wishes biotechs flock to Mirai to improve genetic meds

.Amidst the genetic medicines arms nationality, Front runner Pioneering is actually unveiling a bran...

BioAge eyes $180M from IPO, personal positioning for obesity trials

.BioAge Labs is eyeing all around $180 thousand in first profits coming from an IPO and also a perso...

Merck's LAG-3 combo stops working intestines cancer cells period 3 research

.An attempt by Merck &amp Co. to open the microsatellite dependable (MSS) metastatic colorectal canc...

Spanish VC closes $200M life scientific researches fund

.Spain-based Asabys Allies has actually closed a fund of 180 thousand europeans ($ 200 million), mon...

BioAge generates $198M from IPO as excessive weight biotech joins Nasdaq

.BioAge Labs is generating practically $200 thousand through its own Nasdaq IPO today, with the proc...